Fox Chase Cancer Center
The Fox Chase Cancer Center is a comprehensive cancer center for research, physician training and patient care. The Center was formed in 1974 with the merger of the first cancer hospital, American Oncologic Hospital and the Institute for Cancer Research. Today, Fox Chase Cancer Center located in the Philadelphia, Pennsylvania metro area is a leading research, patient treatment and physician training center. Research takes place in more than 80 labs within the Center and employs more than 325 physicians and scientists.
Philadelphia, PA 19111-2497
Researchers find some lung cancers linked to common virus
A common virus known to cause cervical and head and neck cancers may also trigger some cases of lung cancer, according to new research presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013 on Wednesday, April ...
Cancer
Apr 10, 2013 |
5 / 5 (1) |
0
New technology spots drugs' early impact on cancer
A new preclinical technology enables researchers to quickly determine if a particular treatment is effective against gastrointestinal stromal tumors (GISTs), providing a boost to animal research and possibly patient care, ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Quantifying heterogeneity in breast cancer
A variety of mutations may give rise to breast cancer, but scientists generally assume that it starts off with just a few. That's because later-stage breast cancers tend to have more mutations—they are more heterogeneous—than ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Researchers identify critical metabolic alterations in triple-negative breast cancer cells
Researchers at Fox Chase Cancer Center have identified a host of small molecules critical to metabolism in cells of triple-negative breast cancer—one of the least understood groups of breast cancer. These molecules, called ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Omega-3 fatty acids more effective at inhibiting growth of triple-negative breast cancer
Researchers from Fox Chase Cancer Center have found that omega-3 fatty acids and their metabolite products slow or stop the proliferation, or growth in the number of cells, of triple-negative breast cancer cells more effectively ...
Cancer
Apr 09, 2013 |
4 / 5 (1) |
0
New treatment holds promise for resistant lung cancer
A new chemotherapy regimen appears to produce minimal side effects in patients with lung cancer that has not responded to previous therapy, paving the way for additional research to determine if the new regimen also helps ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Researchers show that a promising drug can help prevent head and neck cancers
Head and neck cancers typically begin in squamous cells that line moist surfaces inside the mouth, nose and throat. Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most common type of cancer in the United ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Exploring lincRNA's role in breast cancer
Once considered part of the "junk" of our genome, much of the DNA between protein-coding genes is now known to be transcribed. New findings by scientists at Fox Chase Cancer Center have identified several dozen transcripts ...
Cancer
Apr 08, 2013 |
not rated yet |
0
Current HPV vaccine may not help some women with immune problems
Women with HIV acquire cancer-causing forms of the human papillomavirus (HPV) that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center being presented ...
Cancer
Apr 07, 2013 |
5 / 5 (1) |
0
|
Different drug combinations work best for prevention versus treatment of colorectal tumors
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Once colorectal cancer has spread to other parts of the body, only 11 percent of patients will survive five years from the date ...
Cancer
Apr 07, 2013 |
1 / 5 (1) |
0
Researchers find that two antagonistic proteins help keep leukemia at bay, pointing to new potential treatments
Two proteins that scientists once thought carried out the same functions are actually antagonists of each other, and keeping them in balance is key to preventing diseases such as cancer, according to new findings published ...
Cancer
Feb 27, 2013 |
5 / 5 (1) |
0
|
Scientists find a new way to boost common cancer drugs
Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue ...
Cancer
Jan 14, 2013 |
5 / 5 (2) |
0
|
Researchers discover novel role of the NEDD9 gene in early stages of breast cancer
Breast cancer is the second leading cause of cancer deaths among women in the United States. Many of these deaths occur when there is an initial diagnosis of invasive or metastatic disease. A protein called NEDD9—which ...
Cancer
Jan 14, 2013 |
not rated yet |
0
|
Researchers develop novel 3-D culture system for inflammatory breast cancer
Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the ...
Cancer
Dec 09, 2012 |
not rated yet |
0
|
New small molecule inhibitor could be a safe and first-line treatment for metastatic breast cancer
Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, ...
Cancer
Dec 08, 2012 |
not rated yet |
0
